Blanket Purchase Agreement 36C25926A0015
- Not listed
- Veracyte Labs SD Corporation, operating as the Decipher Biosciences, Inc. Division, was awarded a single-award Blanket Purchase Agreement valued at $1.95 million by Veterans Integrated Service Network 1, a civilian entity within the Department of Veterans Affairs, with an ultimate completion date of January 31, 2028. The contract, established under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), procures prostate cancer...
- The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the provision of Decipher Prostate Cancer Testing services. This contract, valued at up to $991,815.95, is established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not have a set-aside designation. The contract aims to support the VA's efforts to provide personalized,...
- Veracyte Labs SD Corporation (Decipher Biosciences, Inc. division) was awarded a single-award Blanket Purchase Agreement valued at $972,177 by Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs, effective February 8, 2023, with an ultimate completion date of January 31, 2028. Operating under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), this indefinite...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery, indefinite quantity contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., with a potential value of $249,000.00 and a period of performance through September 30, 2023. Against this contract, the agency issued four firm fixed price delivery orders for prostate cancer testing services. The orders called for providing the proprietary...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Myriad Genetic Laboratories Inc. a blanket purchase agreement to provide Prolaris prostate cancer testing services. Three firm fixed price call contracts were placed against the BPA between 2021 and 2024, with a combined value of $74,970. As the prime, Myriad will deliver the genomic testing to the VA Salt Lake City Health Care System in Utah. This testing assists with disease risk...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Veterans Health Administration (VHA) to Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division. The BPA has a total ceiling value of $335,800 and is for the provision of Oncotype DX cancer testing services, including gene expression profiling and genomic testing, to support federal healthcare programs. The contract utilizes Exact Sciences' Federal Supply...
- The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, a medical technology company specializing in cancer diagnostic testing services. The BPA has a ceiling value of $497,370.24 and a period of performance through August 31, 2025. Under this contract, Exact Sciences Laboratories, LLC, a division of Exact Sciences Corporation, will provide medical laboratory testing and analysis services, including gene expression...
- Veracyte, Inc., headquartered in South San Francisco, California, holds a multiple-award Federal Supply Schedule contract (FSS-621-II) for Medical Laboratory Testing and Analysis Services with a ceiling value of $2.3 million and a performance period from August 1, 2018, through July 31, 2028. The contract is funded through the Department of Veterans Affairs, Veterans Integrated Service Network 12, on a civilian basis with no set-aside designation. Veracyte delivers advanced genomic sequencing...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq genomic classifier tests. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, and has held multiple federal contracts with the VA and Defense Health Agency to deliver ThyroSeq testing to support cancer screening and diagnosis programs for...
- 36C25926A0015Blanket Purchase Agreement
- 1Federal Contract Awards
Veterans Integrated Service Network 2 established a Blanket Purchase Agreement with Veracyte Labs SD Corporation on June 1, 2026, under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), with a ceiling value of $486,088.50 and performance through May 31, 2027. The BPA procures prostate cancer genomic testing services, specifically the Decipher Prostate Cancer Test, a genomic classifier that analyzes tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential for VA patient populations. Work is performed in San Diego, California 92121. The originating solicitation, posted March 16, 2026, sought prostate testing services for Salt Lake City VA Medical Center under a five-year blanket purchase agreement, with an estimated quantity of 30 tests per year across five ordering periods from May 1, 2026, through April 30, 2031. NAICS code 621511 (Medical Laboratories) applies. The contractor must be fully licensed and accredited by the College of American Pathologists and certified under CLIA, maintain HIPAA compliance, implement quality assurance programs, retain specimens per regulatory requirements (minimum seven days for clinical specimens), and transmit results via encrypted electronic methods. A BPA call was issued on June 1, 2026, for $97,217.70 with a completion date of May 31, 2027, priced firm fixed-price with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 5/28/26 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C25926A0015-36C25926N0347 | Veracyte Labs SD Corporation | $97.2k | 6/1/26 | 5/31/27 | 5/28/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--Prostate Testing for Salt Lake City VA Medical Center | 36C25926Q0178 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 | Solicitation 1/2 | 3/16/26, 2:30 PM | |
Q301--5 Year BPA Decipher Prostate Test | 36C25926Q0178 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 | Award Notice 2/2 | 5/29/26, 4:50 PM |